Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (Weighted Average) (2018 - 2025)

Health Catalyst (HCAT) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $70.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 18.38% year-over-year to $70.4 million, compared with a TTM value of $70.4 million through Sep 2025, up 18.38%, and an annual FY2024 reading of $60.2 million, up 6.68% over the prior year.
  • Shares Outstanding (Weighted Average) was $70.4 million for Q3 2025 at Health Catalyst, up from $69.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $70.4 million in Q3 2025 and bottomed at $43.9 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $56.3 million, with a median of $55.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 27.21% in 2021, then rose 3.24% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $47.5 million in 2021, then rose by 13.11% to $53.7 million in 2022, then rose by 5.02% to $56.4 million in 2023, then increased by 6.68% to $60.2 million in 2024, then grew by 16.93% to $70.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for HCAT at $70.4 million in Q3 2025, $69.6 million in Q2 2025, and $68.6 million in Q1 2025.